Bixiye
Immune Globulins - Medicaid
Oggolaanshaha Hore
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2024
Natiijooyinka Raadinta
Soo bandhiga 2031 - 2040 ee natiijooyinka 3690
Bixiye
Bonjesta®, Diclegis® - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2024
Bixiye
Bempedoic Acid - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2024
Bixiye
Gattex® (teduglutide) - Commercial
Oggolaanshaha Hore
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2024
Bixiye
Egrifta® (tesamorelin) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2024
Bixiye
Egrifta® (tesamorelin) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2024
Bixiye
QP76-21 Commercial and MHCP Pharmacy Benefit Exclusion for Uptravi®
Taariikhda uu dhaqangalayo barnaamijka: Okt 13, 2021
Bixiye
QP77-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective December 1, 2021
Taariikhda uu dhaqangalayo barnaamijka: Okt 13, 2021
Bixiye
QP82-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Accrufer™ (ferric maltol)
Taariikhda uu dhaqangalayo barnaamijka: Okt 27, 2021